Why Patients Consider Switching From Mounjaro To Wegovy
Online Prescription Process For Swapping From Mounjaro To Wegovy
The online prescription process for patients wanting to swap from Mounjaro to Wegovy has been designed for clinical safety and convenience. Our 3-minute assessment covers your current Mounjaro experience, including dosage, duration of treatment, and any side effects that may be influencing your decision to switch. Licensed UK prescribers review every case individually, ensuring appropriate timing for the transition and determining the correct starting dose based on your previous tirzepatide exposure.
The assessment includes detailed questions about your weight management journey, medical history, and specific reasons for considering the swap from Mounjaro to Wegovy. Most approvals are processed within 3 working days, with express 24-hour review available for urgent cases. Your prescriber will provide clear transition guidance, including any recommended wash-out period if clinically necessary. This thorough approach ensures your switch is managed safely whilst maintaining continuity in your weight management programme.
Wegovy Pricing Structure For Patients Switching From Mounjaro
Understanding Wegovy pricing helps patients budget effectively when making the swap from Mounjaro to Wegovy. Single pen prices start at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers benefit from code FIRST40 applied at checkout, whilst returning customers use code DOSE25. These discount codes are automatically applied to reach the final prices quoted above.
Bundle options provide supply convenience for those committed to the swap from Mounjaro to Wegovy. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering the first 8 weeks of treatment. The Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 supports the crucial dose escalation phase. For maintenance patients, the Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. Our GPhC-registered pharmacy (#9012878) ensures all pricing is transparent with no hidden fees or subscription charges.
Clinical Evidence Supporting The Swap From Mounjaro To Wegovy
Patients considering the swap from Mounjaro to Wegovy benefit from robust clinical evidence supporting semaglutide's efficacy. The STEP trial programme, including the landmark Wilding et al., NEJM, 2021 study, demonstrated that participants taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks. The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, providing additional reassurance for patients making the switch.
Both Wegovy and Mounjaro are prescription-only medicines with different mechanisms of action that may suit different patient profiles. Wegovy works as a GLP-1 receptor agonist, whilst Mounjaro targets both GIP and GLP-1 receptors as a dual agonist. Clinical trials cannot be directly compared due to different study designs and populations, but both treatments have demonstrated significant efficacy in their respective programmes when used alongside reduced-calorie diet and increased physical activity.
Understanding How Wegovy Works After Mounjaro Treatment
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone GLP-1 that regulates appetite and glucose levels. Unlike Mounjaro's dual GIP/GLP-1 mechanism, Wegovy specifically targets GLP-1 receptors to reduce appetite and promote feelings of fullness after smaller meals. This focused approach may suit patients who experienced certain side effects with Mounjaro's broader receptor activation. The once-weekly injection stimulates insulin release when blood glucose is elevated whilst slowing gastric emptying to extend satiety. Many patients report reduced food cravings as Wegovy acts on brain appetite centres, supporting long-term adherence to reduced-calorie diets.
Step-By-Step Process For Getting Wegovy After Mounjaro
The transition process begins with completing our comprehensive clinical assessment, specifically designed for patients wanting to swap from Mounjaro to Wegovy. Questions address your current tirzepatide treatment, including dosage, duration, efficacy, and tolerability concerns prompting the switch. Licensed UK prescribers review your submission within 3 working days (24 hours with express service), considering factors like wash-out requirements and appropriate Wegovy starting dose. Once approved, your prescription-only medicine is dispatched via next-day cold-chain delivery with temperature monitoring throughout transit. Our pharmacy team coordinates timing to ensure seamless continuity in your weight management programme without unnecessary treatment gaps.
Storage Advantages When Making The Swap From Mounjaro To Wegovy
One significant practical advantage driving the swap from Mounjaro to Wegovy is superior storage flexibility. Wegovy pens maintain stability for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit. This extended stability benefits frequent travellers, business professionals, and those with inconsistent refrigerator access. The FlexTouch pen design provides reliable dose delivery with clear dosage windows and audible clicks confirming injection completion. Proper dose escalation remains essential, starting at 0.25mg weekly regardless of previous Mounjaro dosing, then increasing monthly through 0.5mg, 1mg, 1.7mg to reach 2.4mg maintenance dosing.
Personalised Treatment Planning For Mounjaro To Wegovy Transitions
Every swap from Mounjaro to Wegovy requires individualised clinical consideration based on your specific treatment history and switching rationale. Our prescribers assess factors including your highest tolerated Mounjaro dose, treatment duration, weight loss achieved, and side effect profile. This information guides decisions about transition timing and whether a brief wash-out period might be clinically beneficial. Some patients may require modified dose escalation schedules based on their GLP-1 receptor agonist experience.
The transition planning also considers lifestyle factors that influenced your decision to switch treatments. Enhanced storage stability, different injection day preferences, or insurance coverage changes all factor into creating a seamless changeover. Your dedicated prescriber provides written transition instructions, including emergency contact details and clear guidance about managing any temporary side effects during the switch. This comprehensive approach ensures your swap from Mounjaro to Wegovy optimises both safety and treatment continuity.
Complete Your Wegovy Prescription Today
Ready to make the swap from Mounjaro to Wegovy? Start your 3-minute clinical assessment now through our secure online platform. New customers save with code FIRST40, whilst returning patients use DOSE25, both applied automatically at checkout. Your application receives priority review from our experienced prescribing team who understand the nuances of GLP-1 treatment transitions. Once approved, enjoy next-day delivery of your prescription-only medicine with full cold-chain protection. Visit https://everydaymeds.co.uk/collections/wegovy to begin your transition today with confidence in our GPhC-registered service (#9012878).
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
